The Trump administration’s claims about Tylenol and autism — and the weak science used to support them — must be called out for what they are: reckless, disappointing, and dangerous, says Ashish K. Jha.
Dr. Ashish Jha, Dean of the School of Public Health at Brown University, joins ‘Fast Money’ to discuss new government guidance on Tylenol use during pregnancy, why leading studies show no link to autism, the reaction from obstetricians, and the challenges facing women navigating medication options, and much more.
Dr. Ashish K. Jha, dean of Brown University School of Public Health, says the problem with RFK Jr.’s MAHA report is it falls short in its honesty, its innovation, and the evidence.
Dr. Ashish K. Jha is dean of Brown University School of Public Health and a contributing Globe Opinion writer:
Over the past decade, the United States has made meaningful progress in expanding health coverage and improving care for millions of Americans. But that progress is now in jeopardy. The newly passed “One Big Beautiful Bill Act” will have far-reaching consequences for the health insurance of millions of Americans. The Congressional Budget Office estimates that nearly 10 million Americans could lose their health insurance by 2034 as a result of the new legislation. In Massachusetts, officials estimate 300,000 people are at risk of losing their health coverage.
